NASDAQ: MYOK       Myokardia Inc
Last Price Today's Change   Day's Range   Trading Volume
66.70   +1.43 (2.19%)  65.27 - 67.09  280,300


Avg Volume (4 weeks):361,031
4 Weeks Range:53.71 - 68.60
4 Weeks Price Volatility (%):
52 Weeks Range:39.01 - 68.60
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

MyoKardia Inc is a US-based clinical-stage biopharmaceutical company which is engaged in discovering, developing and commercializing targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. The company mainly focuses on the treatment of heritable cardiomyopathies and genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. It uses its medicine platform to generate an initial pipeline of therapeutic programs for the chronic treatment of the two most common forms of heritable cardiomyopathy—hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy. The company’s products include MYK-461 s an orally administered small molecule to reduce excessive cardiac muscle contractility leading to HCM.

  Be the first to like this.


3995  4101  641  182 

Top 10 Active Counters
 CELG 108.24+0.11 
 EEM 44.42-0.02 
 SPY 317.32+0.19 
 AMD 41.15-1.44 
 VXX 15.53-0.67 
 DHR 148.52-2.78 
 CHK 0.789+0.006 
 FXI 42.60-0.18 
 GE 11.34-0.10 
 BAC 34.44-0.24 
Partners & Brokers